| Home | Contact us | Search
 

One off donation
Regular donation

Follow news of the Fund as it builds its base of supporters and activities across the UK and important events in the world of kidney cancer.

This conference was attended by the Fund's Medical Publications Officer who has written the following report

 NICE ANNUAL CONFERENCE 2011 REPORT

 

 

 
James Whale Fund defends challenges cancer experts on acces to drugs
Last month, a group of 37 cancer experts put their names to a report in the Lancet Oncology journal to condemn what they claim to be a 'culture of excess' which has led doctors to 'overtreat, overdiagnose and overpromise' when it comes to cancer medicines. >>
James Whale Fund defends challenges cancer experts on access to drugs
Last month, a group of 37 cancer experts put their names to a report in the Lancet Oncology journal to condemn what they claim to be a 'culture of excess' which has led doctors to 'overtreat, overdiagnose and overpromise' when it comes to cancer medicines. >>
Don't give out cancer drugs if it's just to extend life:

Don't give out cancer drugs if it's just to extend life: Treatment costs can't be justified, say experts

Sophie Borland, Dail Mail >>
Clive Stone, recommended for MBE by David Cameron, is denied life saving drugs by NHS
Hear our Patient Advocate Rose Woodward, speaking about it on Radio Oxford on 10 May. >>
RCC treatment options in British Journal of Nursing May 2011
Sharon Deveson Kell Bsc PhD MBA, the Fund's Medical Publications Officer, discusses RCC treatment options in this month's issue. >>
Kidney cancer raised in House of Lords by James Whale Fund representative
  >>
The PREDICT Consortium Launch
Thursday 20 January 2011 saw the launch of the PREDICT Consortium; a very exciting day for the future of research into the treatment of kidney cancer. >>
Share |